Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist peptide analogue with an acylated fatty acid side chain conferring extended plasma half-life. Preclinical and clinical research has examined its binding kinetics at the GLP-1 receptor, downstream cAMP signaling cascades, and pancreatic beta-cell receptor activation in controlled in vitro and animal model systems. Published literature has also explored its pharmacokinetic parameters including subcutaneous bioavailability, volume of distribution, and renal clearance characteristics under research conditions.
\n
Class: GLP-1 Receptor Agonist Analogue | Purity: ≥98% (HPLC) | Format: Lyophilized powder
\n
Storage: −20°C, desiccated, protected from light | Reconstitution: Bacteriostatic water recommended for research use
\n
\n
⚠️ Research Use Only. This compound is intended exclusively for qualified in vitro and laboratory research. It is not approved for human consumption, is not a dietary supplement, and has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or health condition. Researchers are solely responsible for compliance with all applicable federal, state, and local laws governing research chemical use.
